You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

acalabrutinib

Showing 51 - 75 of 86
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Richter's Syndrome Trial in Italy, United Kingdom, United States

Active, not recruiting
Has Results
  • Chronic Lymphocytic Leukemia
  • +3 more
  • Acalabrutinib
  • Boston, Massachusetts
  • +11 more
Nov 23, 2022

Hepatic Impairment, Hepatic Insufficiency, Healthy Subjects Trial in Miami, Orlando, Knoxville (acalabrutinib)

Completed
Has Results
  • Hepatic Impairment
  • +2 more
  • acalabrutinib
  • Miami, Florida
  • +2 more
Aug 16, 2021

Grade 1 Follicular Lymphoma, Grade 2 Follicular Lymphoma, Grade 3a Follicular Lymphoma Trial in Atlanta (drug, biological,

Recruiting
  • Grade 1 Follicular Lymphoma
  • +7 more
  • Acalabrutinib
  • +3 more
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Dec 7, 2021

Part1: Advanced B-cell Malignancies, Part2: r/rCLL and r/rMCL, Part3: Untreated CLL Trial in Japan (Acalabrutinib, Obinutuzumab)

Active, not recruiting
  • Part1: Advanced B-cell Malignancies
  • +2 more
  • Chiba-shi, Japan
  • +13 more
Jan 31, 2022

Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Trial in Worldwide (Acalabrutinib, Venetoclax, Obinutuzumab)

Recruiting
  • Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
  • Acalabrutinib
  • +2 more
  • Tucson, Arizona
  • +40 more
Dec 20, 2022

Untreated Chronic Lymphocytic Leukemia Trial in Worldwide (Acalabrutinib, Rituximab, Chlorambucil)

Recruiting
  • Untreated Chronic Lymphocytic Leukemia
  • Acalabrutinib
  • +2 more
  • Beijing, China
  • +50 more
Sep 26, 2022

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Boston (Venetoclax, Obinutuzumab, Acalabrutinib)

Recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Boston, Massachusetts
  • +2 more
Aug 9, 2021

Healthy Volunteers Trial in Tempe (Acalabrutinib, SmartPill®)

Completed
  • Healthy Volunteers
  • Tempe, Arizona
    Celerion
Jun 2, 2021

Healthy Volunteers Trial in Madison (Acalabrutinib, Microtracer [14C]ACP-196)

Completed
  • Healthy Volunteers
  • Acalabrutinib
  • Microtracer [14C]ACP-196
  • Madison, Wisconsin
    Covance Clinical Research Unit, Inc.
May 21, 2021

CLL Trial in Denmark, Netherlands, Sweden (Acalabrutinib, Venetoclax)

Recruiting
  • CLL
  • Copenhagen, Denmark
  • +5 more
Sep 17, 2021

Chronic Lymphocytic Leukemia Trial in Germany (Obinutuzumab, Venetoclax, Acalabrutinib)

Recruiting
  • Chronic Lymphocytic Leukemia
  • Bad Saarow, Germany
  • +29 more
May 4, 2022

Mantle Cell Lymphoma Trial in United States (Acalabrutinib)

Recruiting
  • Mantle Cell Lymphoma
  • Acalabrutinib
  • Denver, Colorado
  • +3 more
May 20, 2021

DLBCL Trial in Houston (Acalabrutinib, Cyclophosphamide, Doxorubicin Hydrochloride)

Recruiting
  • Diffuse Large B-Cell Lymphoma
  • Acalabrutinib
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 10, 2022

Mantle Cell Lymphoma Trial in United States (Acalabrutinib, Bortezomib, Cyclophosphamide)

Recruiting
  • Mantle Cell Lymphoma
  • Acalabrutinib
  • +7 more
  • New Orleans, Louisiana
  • +5 more
Dec 13, 2022

Diffuse Large B Cell Lymphoma, Chronic Lymphocytic Leukemia, Non Hodgkin Lymphoma Trial in Worldwide (KRT-232, acalabrutinib)

Recruiting
  • Diffuse Large B Cell Lymphoma
  • +2 more
  • Goshen, Indiana
  • +44 more
Aug 3, 2022

Diffuse Large B-cell Lymphoma Trial in Switzerland (Acalabrutinib)

Recruiting
  • Diffuse Large B-cell Lymphoma
  • Acalabrutinib
  • Bergamo, Italy
  • +16 more
Jan 17, 2023

COVID-19 Trial in United States (Acalabrutinib)

Completed
Has Results
  • COVID-19
  • Acalabrutinib
  • Anniston, Alabama
  • +30 more
Sep 8, 2021

Infectious Disease Trial in Anaheim (Acalabrutinib, Rabeprazole)

Completed
  • Infectious Disease
  • Anaheim, California
    Research Site
Oct 29, 2020

Relapsed/Refractory Trial in Santa Fe (Tafasitamab, Lenalidomide, Tazemetostat)

Recruiting
  • Relapsed/Refractory
  • Santa Fe, California
    California Cancer Associates For Research And Excellence, cCARE
Feb 23, 2022

Mantle Cell Lymphoma Trial in Houston (Acalabrutinib, Rituximab)

Not yet recruiting
  • Mantle Cell Lymphoma
  • Acalabrutinib
  • Rituximab
  • Houston, Texas
    M D Anderson Cancer Center
Feb 24, 2021

COVID-19 Trial in Worldwide (Acalabrutinib)

Completed
Has Results
  • COVID-19
  • Acalabrutinib
  • Ciudad de Buenos Aires, Argentina
  • +49 more
Sep 15, 2021

Covid19 Trial in Kingston (Remdesivir, Acalabrutinib, Interferon beta-1a)

Not yet recruiting
  • Covid19
  • Kingston, Jamaica
    Univeristy of the West Indies
May 10, 2021

DLBCL, Richter Syndrome Trial in United Kingdom, United States (acalabrutinib, vistusertib)

Terminated
Has Results
  • DLBCL
  • Richter Syndrome
  • Fairway, Kansas
  • +10 more
Jan 4, 2021

Chronic Lymphocytic Leukemia Trial in Worldwide (Acalabrutinib, Venetoclax, Chemoimmunotherapy)

Recruiting
  • Chronic Lymphocytic Leukemia
  • Acalabrutinib
  • +3 more
  • Fountain Valley, California
  • +201 more
Jan 16, 2023

NHL, DLBCL, Non-hodgkin's Lymphoma Trial in United Kingdom, United States (AZD9150, Acalabrutinib, AZD6738)

Completed
  • NHL
  • +3 more
  • Los Angeles, California
  • +11 more
Aug 11, 2022